Search results
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
2 years ago
Following the release at ESC 2021 of updated guidelines for the diagnosis and treatment of acute and chronic heart failure, Prof Andrew Coats (Monash University, Australia and University of Warwick, UK) and Prof Giuseppe Rosano (St George's, University of London, UK) discuss the implications for treatment strategies.
This three-part series provides comprehensive update on some of the most…
View more
Author(s):
Andrew JS Coats
,
Harriette Van Spall
,
Faiez Zannad
Added:
3 years ago
Thisprogramme focuses on assessingrecent data on SGLT2 inhibitors that showthey reduce CV outcomes, HF hospitalisations and mortality in HFrEF patients irrespective of T2DM.
The expert panel also discuss how new data from the EMPEROR-Reduced trial should be interpreted against complementary SGLT2 data and how these agents should be utilised in clinical practice.
View more
Author(s):
Andrew JS Coats
,
Biykem Bozkurt
,
Carolyn Lam
Added:
2 years ago
SGLT-2 inhibitors represent one of the single biggest advances in heart failure practice, but how confident are you when comes to using them in different patients, and what can we reasonably expect in the coming months and years from ongoing trials?
Watch our esteemed faculty – Prof Andrew Coats, Dr Biykem Bozkurt and Prof Carolyn Lam as they summarise the latest SGLT-2 inhibitor data in…
View more
Author(s):
Peter Jakobsson Ueda
Added:
5 years ago
Dr Peter Jakobsson Ueda discusses the cohort study of serious adverse events with SGLT2 inhibitors, filmed byRadcliffe Cardiology on site in Munich, ESC 2018.
View more
Start date:
Aug 29, 2022
End date:
Aug 29, 2022
Radcliffe Medical Education is delighted to introduce the live programme ‘SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure’ onsite in Barcelona, and online, around the world.
Chaired by Prof Scott Solomon (Boston, US), this session will bring together a leading international faculty of Prof John McMurray (Glasgow, UK), Prof Carolyn Lam (Singapore, SG) and Dr Muthiah Vaduganathan …
View more
Author(s):
Anupam A Kumar
,
Lena E Tran
,
Aniket S Rali
,
et al
Added:
1 year ago
Author(s):
Giuseppe Rosano
,
Ilaria Spoletini
,
Cristiana Vitale
,
et al
Added:
3 years ago
Heart failure (HF) affects 1–2% of the population in developed countries and absorbs a significant amount of human and economic resources.1,2 HF is a complex syndrome characterised by a spectrum of symptoms and phenotypes: HF with preserved ejection fraction, HF with mid-range ejection fraction and HF with reduced ejection fraction (HFrEF).3 Differentiating patients according to left ventricular…
View more
Author(s):
Akshay S Desai
,
Carolyn Lam
Added:
4 years ago
Prof Carolyn Lam, National Heart Center, Singapore and Dr Akshay Desai, Brigham and Women’s Hospital, Boston, US, discuss guidelines, data and ongoing trials around SGLT2 inhibitors in heart failure at AHA 2019, held in Philadelphia in November 2019.
This peer-to-peer discussion was funded by an unrestricted educational grant from Boehringer Ingelheim.
Filmed on-site by Radcliffe Cardiology…
View more
European Heart Failure Guideline Updates: A Peer-to-Peer Discussion on SGLT-2 Inhibitors
Author(s):
Andrew JS Coats
,
Carolyn Lam
Added:
2 years ago
Video Series
Author(s):
Marc S Sabatine
,
Lars Kober
Added:
4 years ago
Mark Sabatine & Lars Kober analyse the latest SGLT2 data presented at ESC 2019
View more